Artivion | CRY - Interest Expense On Debt

Stock Price
37.76
Daily Change
0.60 1.61%
Monthly
4.54%
Yearly
58.39%
Q2 Forecast
36.95

Artivion reported $5.53M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Abbott USD 68M 26M Mar/2026
Accuray USD 2.88M 72K Dec/2024
AngioDynamics USD 102K 2K Sep/2025
Artivion USD 5.53M 589K Dec/2025
AtriCure USD 1.33M 17K Sep/2025
Baxter International USD 58M 14M Sep/2025
Becton, Dickinson and Co. USD 153M 2M Dec/2025
Boston Scientific USD 90M 0 Mar/2026
Edwards Lifesciences USD 35.9M 2.7M Dec/2025
Inogen 1.03M 384K Mar/2025
Integra LifeSciences USD 23.67M 953K Dec/2025
J&J USD 43M 25M Mar/2026
Mesa Laboratories USD 3.02M 180K Sep/2024
Orthofix International 4.68M 731K Sep/2025
Pfizer USD 711M 59M Dec/2025
ResMed USD 8.79M 14.55M Sep/2025
Stryker USD 157M 46.17B Sep/2025
Surmodics USD 884K 5K Sep/2024
Tandem Diabetes Care USD 2.07M 872.58M Dec/2025
Teleflex USD 28.15M 3.69M Dec/2025
Terumo JPY 463M 445M Dec/2025
Trinity Biotech USD 3.33M 50K Sep/2025